EE200100065A - Zofenopriili kaltsiumisoola valmistamise meetod - Google Patents

Zofenopriili kaltsiumisoola valmistamise meetod

Info

Publication number
EE200100065A
EE200100065A EEP200100065A EEP200100065A EE200100065A EE 200100065 A EE200100065 A EE 200100065A EE P200100065 A EEP200100065 A EE P200100065A EE P200100065 A EEP200100065 A EE P200100065A EE 200100065 A EE200100065 A EE 200100065A
Authority
EE
Estonia
Prior art keywords
zofenopril
salt
calcium salt
preparation
potassium salt
Prior art date
Application number
EEP200100065A
Other languages
English (en)
Inventor
Giorgi Raffaello (Surnud)
Giachetti Antonio
Mannucci Carlo
Falezza Anita
Original Assignee
Menarini Ricerche S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche S.P.A. filed Critical Menarini Ricerche S.P.A.
Publication of EE200100065A publication Critical patent/EE200100065A/et
Publication of EE04798B1 publication Critical patent/EE04798B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200100065A 1998-08-04 1999-07-30 Zofenopriili kaltsiumisoola valmistamise meetod EE04798B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001833A IT1301993B1 (it) 1998-08-04 1998-08-04 Processo per la preparazione di zofenopril sale di calcio.
PCT/EP1999/005461 WO2000007984A1 (en) 1998-08-04 1999-07-30 A process for the preparation of zofenopril calcium salt

Publications (2)

Publication Number Publication Date
EE200100065A true EE200100065A (et) 2002-06-17
EE04798B1 EE04798B1 (et) 2007-04-16

Family

ID=11380611

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100065A EE04798B1 (et) 1998-08-04 1999-07-30 Zofenopriili kaltsiumisoola valmistamise meetod

Country Status (32)

Country Link
US (2) US6521760B1 (et)
EP (1) EP1102745B1 (et)
JP (1) JP2002522417A (et)
KR (1) KR100593428B1 (et)
CN (1) CN1146538C (et)
AT (1) ATE266635T1 (et)
AU (1) AU5372299A (et)
BG (1) BG65022B1 (et)
BR (1) BR9912842A (et)
CA (1) CA2339283C (et)
CU (1) CU23171A3 (et)
CZ (1) CZ301908B6 (et)
DE (1) DE69917282T2 (et)
DK (1) DK1102745T3 (et)
EA (1) EA003454B1 (et)
EE (1) EE04798B1 (et)
ES (1) ES2221417T3 (et)
HK (1) HK1039616B (et)
HR (1) HRP20010083B1 (et)
HU (1) HU227557B1 (et)
IL (1) IL141222A0 (et)
IT (1) IT1301993B1 (et)
NO (1) NO319773B1 (et)
PL (1) PL193828B1 (et)
PT (1) PT1102745E (et)
RS (1) RS49768B (et)
SI (1) SI1102745T1 (et)
SK (1) SK285527B6 (et)
TR (1) TR200100272T2 (et)
UA (1) UA65628C2 (et)
WO (1) WO2000007984A1 (et)
ZA (1) ZA200100907B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2560502T3 (es) 2005-07-01 2016-02-19 Generics [Uk] Limited Zofenopril calcio en forma de polimorfo C
EA012845B1 (ru) * 2005-12-09 2009-12-30 Менарини Интернэшнл Оперейшнс Люксембург С. А. Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии
DK2041083T3 (en) * 2006-05-26 2015-01-26 Generics Uk Ltd Methods for the preparation of zofenopril calcium
GB0715626D0 (en) 2007-08-10 2007-09-19 Generics Uk Ltd Crystalline form of zofenopril calcium
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
CN101981004B (zh) * 2008-02-27 2014-09-17 基因里克斯(英国)有限公司 晶体形式
EP2389360A4 (en) * 2009-01-23 2013-01-16 Glenmark Generics Ltd METHOD FOR PRODUCING ZOFENOPRIL AND PHARMACEUTICAL ACCEPTIC SALTS THEREFOR
SI23949A (sl) 2011-12-19 2013-06-28 Silverstone Pharma Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 佐芬普利钙片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines

Also Published As

Publication number Publication date
HUP0103826A3 (en) 2002-03-28
CZ301908B6 (cs) 2010-07-28
PT1102745E (pt) 2004-08-31
IT1301993B1 (it) 2000-07-20
ITMI981833A1 (it) 2000-02-04
NO319773B1 (no) 2005-09-12
CU23171A3 (es) 2006-09-22
ES2221417T3 (es) 2004-12-16
SK1632001A3 (en) 2001-09-11
DE69917282D1 (de) 2004-06-17
CA2339283C (en) 2009-03-17
CN1316992A (zh) 2001-10-10
US6521760B1 (en) 2003-02-18
CZ2001408A3 (cs) 2001-07-11
BG65022B1 (bg) 2006-12-29
HU227557B1 (en) 2011-08-29
EE04798B1 (et) 2007-04-16
BG105176A (en) 2001-11-30
PL193828B1 (pl) 2007-03-30
HRP20010083A2 (en) 2002-02-28
ATE266635T1 (de) 2004-05-15
HK1039616A1 (en) 2002-05-03
TR200100272T2 (tr) 2001-05-21
ZA200100907B (en) 2001-10-04
HUP0103826A2 (hu) 2002-02-28
KR20010072171A (ko) 2001-07-31
DK1102745T3 (da) 2004-08-02
NO20010552L (no) 2001-02-01
SK285527B6 (sk) 2007-03-01
UA65628C2 (uk) 2004-04-15
IL141222A0 (en) 2002-03-10
US20020156293A1 (en) 2002-10-24
EA003454B1 (ru) 2003-06-26
EP1102745B1 (en) 2004-05-12
BR9912842A (pt) 2001-10-16
KR100593428B1 (ko) 2006-06-28
RS49768B (sr) 2008-06-05
AU5372299A (en) 2000-02-28
EP1102745A1 (en) 2001-05-30
US6515012B2 (en) 2003-02-04
ITMI981833A0 (it) 1998-08-04
EA200100095A1 (ru) 2001-08-27
HRP20010083B1 (en) 2005-02-28
CA2339283A1 (en) 2000-02-17
WO2000007984A1 (en) 2000-02-17
JP2002522417A (ja) 2002-07-23
NO20010552D0 (no) 2001-02-01
PL345814A1 (en) 2002-01-14
YU7501A (sh) 2005-06-10
SI1102745T1 (en) 2004-10-31
HK1039616B (zh) 2004-10-08
DE69917282T2 (de) 2005-05-25
CN1146538C (zh) 2004-04-21

Similar Documents

Publication Publication Date Title
BR0308385A (pt) Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso
EE200100065A (et) Zofenopriili kaltsiumisoola valmistamise meetod
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
ATE354541T1 (de) Verfahren zur gewinnung von natriumarmem salz aus bitterwässern
CA2425615A1 (en) Process for the purification of gabapentin using a strong cation exchange resin
MA29690B1 (fr) Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine
DK1113990T3 (da) Fremgangsmåde til fremstilling af miljøvenlige krystaller af natriumchlorid
KR970001305A (ko) 발린 정제 방법
EA200501734A1 (ru) Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
AU8182701A (en) Method for producing 5-aminosalicyclic acid
WO2004087939A8 (en) A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia
HRP20000749B1 (en) Purification of carboxaldehyde
White et al. Labeling of amide linkages in active site mapping: Carbonium ion and extended photoaffinity labeling approaches
DK1417324T3 (da) Fremgangsmåde til fremstilling af 2-keto-L-gulonsyre
ATE233728T1 (de) Verfahren zur reinigung von kreatin
KR960004365A (ko) 5'-리보뉴클레오티드칼슘의 제조방법
FR2791682B1 (fr) Procede de preparation du 4'-demethyl-4'-phosphate-2", 3"-bis pentafluorophenoxyacetyl-4",6"-ethyldidene-beta-d- glucoside d'epipodophyllotoxine, et de ses sels
JPS5383994A (en) Production of neutral anhydrous sodium sulfate
RO113970B1 (ro) Procedeu de obţinere a iodurii de potasiu de calitate reactiv
WO2002044155A8 (de) Verfahren zur herstellung von phenylen-bis-benzimidazol-tetrasulfonsäure-dinatriumsalz
WO2007016209A3 (en) Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231